Cleared Traditional

K221592 - AVIEW Lung Nodule CAD (FDA 510(k) Clearance)

Feb 2023
Decision
267d
Days
Class 2
Risk

K221592 is an FDA 510(k) clearance for the AVIEW Lung Nodule CAD. This device is classified as a Lung Computed Tomography System, Computer-aided Detection (Class II - Special Controls, product code OEB).

Submitted by Coreline Soft Co., Ltd. (Seoul, KR). The FDA issued a Cleared decision on February 24, 2023, 267 days after receiving the submission on June 2, 2022.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.2050. To Assist Radiologists In The Review Of Multi-slice Computed Tomography (msct) Exams Of The Chest And Highlight Potential Nodules That The Radiologist Should Review. A Computer Aided Diagnosis, Lung Computed Tomography System Is A Class 3 Device Under Product Code Nrr..

Submission Details

510(k) Number K221592 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 02, 2022
Decision Date February 24, 2023
Days to Decision 267 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code OEB - Lung Computed Tomography System, Computer-aided Detection
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.2050
Definition To Assist Radiologists In The Review Of Multi-slice Computed Tomography (msct) Exams Of The Chest And Highlight Potential Nodules That The Radiologist Should Review. A Computer Aided Diagnosis, Lung Computed Tomography System Is A Class 3 Device Under Product Code Nrr.